[-] Show simple item record

dc.contributor.authorJoseph, Tinaeng
dc.contributor.authorGibbs, Lawrence M.eng
dc.contributor.authorPham, Kimeng
dc.date.issued2022-01eng
dc.description.abstractQ: Are SERMs safe and effective for the treatment of hypogonadism in men? Evidence-based answer: YES. For both normal-weight and obese men with low testosterone levels and hypogonadal symptoms, selective estrogen receptor modulators (SERMs), such as clomiphene citrate (CC) and enclomiphene citrate (EC), appear to be effective and safe for improving serum testosterone levels (strength of recommendation [SOR]: C, disease-oriented outcomes from randomized controlled trials [RCTs] and cohort studies). Studies also show that symptom improvement is comparable to that with exogenous testosterone replacement and similar to eugonadal men (SOR: B, patient-oriented outcomes from retrospective cohort studies).eng
dc.description.bibrefIncludes bibliographical referenceseng
dc.description.statementofresponsibilityTina Joseph, DO; Lawrence M. Gibbs, MD, MSEd, FAAFP; Kim Pham, DO (Methodist Charlton Family Medicine Residency, Dallas, TX)eng
dc.format.extent4 pageseng
dc.identifier.citationThe journal of family practice 71 (1) 2022 E18-E21eng
dc.identifier.urihttps://hdl.handle.net/10355/91367
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2022 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.titleAre SERMs safe and effective for the treatment of hypogonadism in men?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record